NASDAQ: SGHT
Sight Sciences Inc Stock Ownership - Who owns Sight Sciences?

Insider buying vs selling

Have Sight Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David BadawiChief Technology Officer2026-07-067,418$5.51
$40.86kSell
Jeremy B. HaydenChief Legal Officer2026-07-0612,733$5.51
$70.13kSell
James RodbergChief Financial Officer2026-07-026,902$5.36
$36.99kSell
Alison BauerleinChief Operating Officer2026-07-0224,184$5.36
$129.63kSell
Paul BadawiPresident and CEO2026-07-0128,684$5.42
$155.47kSell
Brenton TaylorEVP Operations RD2026-07-012,829$5.42
$15.33kSell
Staffan EncrantzDirector2026-06-1014,100$4.88
$68.79kBuy
Alison BauerleinChief Operating Officer2026-05-1812,728$5.12
$65.17kSell
Jeremy B. HaydenChief Legal Officer2026-04-0613,761$3.55
$48.85kSell
James RodbergChief Financial Officer2026-04-067,231$3.55
$25.67kSell

1 of 5

SGHT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGHT insiders and whales buy or sell their stock.

SGHT Shareholders

What type of owners hold Sight Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Staffan Encrantz11.99%6,521,203$36.06MInsider
Paul Badawi11.25%6,122,472$33.86MInsider
Kck Ltd8.78%4,776,232$26.41MInsider
Long Focus Capital Management LLC6.61%3,594,100$19.88MInstitution
D1 Capital Partners LP5.51%3,000,000$16.59MInsider
Blackrock Inc5.20%2,831,932$15.66MInstitution
Jesse Selnick4.84%2,632,927$14.56MInsider
Pathstone Holdings LLC4.41%2,397,332$13.26MInstitution
Andrew Offer4.33%2,358,224$13.04MInsider
David Badawi3.64%1,982,872$10.97MInsider

1 of 3

SGHT vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGHT41.40%57.22%Net SellingNet Selling
TMCI44.31%55.69%Net BuyingNet Buying
PROF44.96%1.62%
MASS51.71%48.29%Net SellingNet Selling
TLSI33.90%41.16%Net BuyingNet Buying

Sight Sciences Stock Ownership FAQ

Who owns Sight Sciences?

Sight Sciences (NASDAQ: SGHT) is owned by 41.40% institutional shareholders, 57.22% Sight Sciences insiders, and 1.38% retail investors. Staffan Encrantz is the largest individual Sight Sciences shareholder, owning 6.52M shares representing 11.99% of the company. Staffan Encrantz's Sight Sciences shares are currently valued at $36.78M.

If you're new to stock investing, here's how to buy Sight Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.